-
2
-
-
0033910390
-
Immunohistochemical analysis of hepatocellular and adenocarcinoma in the liver: MOC31 compares favorably with other putative markers
-
Porcell AI, Young BRD, Proca DM, et al. Immunohistochemical analysis of hepatocellular and adenocarcinoma in the liver: MOC31 compares favorably with other putative markers. Mod Pathol 2001; 13(7): 773-778.
-
(2001)
Mod Pathol
, vol.13
, Issue.7
, pp. 773-778
-
-
Porcell, A.I.1
Young, B.R.D.2
Proca, D.M.3
-
3
-
-
0036904999
-
A comparison of CD 10 to pCEA, MOC-31, and hepatocyte for the distinction of malignant tumors in the liver
-
Morrison C, Marsh W, Frankel WL. A comparison of CD 10 to pCEA, MOC-31, and hepatocyte for the distinction of malignant tumors in the liver. Mod Pathol 2002; 15(12): 1279-1287.
-
(2002)
Mod Pathol
, vol.15
, Issue.12
, pp. 1279-1287
-
-
Morrison, C.1
Marsh, W.2
Frankel, W.L.3
-
4
-
-
77954315104
-
The best immunohistochemical panel for differentiating hepatocellular carcinoma from metastatic adenocarcinoma
-
Karabork A, Kaygusuz G, Ekinci C. The best immunohistochemical panel for differentiating hepatocellular carcinoma from metastatic adenocarcinoma. Pathol Res Pract 2010; 206(8): 572-577.
-
(2010)
Pathol Res Pract
, vol.206
, Issue.8
, pp. 572-577
-
-
Karabork, A.1
Kaygusuz, G.2
Ekinci, C.3
-
5
-
-
33744784568
-
HepPar1, MOC-31, pCEA, mCEA and CD10 for distinguishing hepatocellular carcinoma vs. metastatic adenocarcinoma in liver fine needle aspirates
-
Wang L, Vuolo M, Suhrland MJ, Schlesinger K. HepPar1, MOC-31, pCEA, mCEA and CD10 for distinguishing hepatocellular carcinoma vs. metastatic adenocarcinoma in liver fine needle aspirates. Acta Cytol 2006; 50(3): 257-262.
-
(2006)
Acta Cytol
, vol.50
, Issue.3
, pp. 257-262
-
-
Wang, L.1
Vuolo, M.2
Suhrland, M.J.3
Schlesinger, K.4
-
6
-
-
0033854049
-
MOC31 immunoreactivity in primary and metastatic carcinoma of the liver. Report of findings and review of other utilized markers
-
Proca DM, Niemann TH, Porcell AI, De Young BR. MOC31 immunoreactivity in primary and metastatic carcinoma of the liver. Report of findings and review of other utilized markers. Appl Immunohistochem Mol Morphol 2000; 8(2): 120-125.
-
(2000)
Appl Immunohistochem Mol Morphol
, vol.8
, Issue.2
, pp. 120-125
-
-
Proca, D.M.1
Niemann, T.H.2
Porcell, A.I.3
de Young, B.R.4
-
7
-
-
16644378805
-
Immunohistochemical and molecular markers in the diagnosis of hepatocellular carcinoma
-
Varma V, Cohen C. Immunohistochemical and molecular markers in the diagnosis of hepatocellular carcinoma. Adv Anat Pathol 2004; 11(5): 239-249.
-
(2004)
Adv Anat Pathol
, vol.11
, Issue.5
, pp. 239-249
-
-
Varma, V.1
Cohen, C.2
-
8
-
-
0027857105
-
Hepatocyte paraffin 1: A monoclonal antibody that reacts with hepatocytes and can be used for differential diagnosisof hepatic tumors
-
Wennerberg AE, Nalesnik MA, Coleman WB. Hepatocyte paraffin 1: A monoclonal antibody that reacts with hepatocytes and can be used for differential diagnosisof hepatic tumors. Am J Pathol 1993; 143: 1050-1054.
-
(1993)
Am J Pathol
, vol.143
, pp. 1050-1054
-
-
Wennerberg, A.E.1
Nalesnik, M.A.2
Coleman, W.B.3
-
9
-
-
0031795529
-
Hep Par 1 and selected antibodies in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma, combined tumours and metastatic carcinoma
-
Leong AS-Y, Sormunen RT, Tsui WMS, Liew CT. Hep Par 1 and selected antibodies in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma, combined tumours and metastatic carcinoma. Histopathology 1998; 33: 318-324.
-
(1998)
Histopathology
, vol.33
, pp. 318-324
-
-
Leong, A.S.-Y.1
Sormunen, R.T.2
Tsui, W.M.S.3
Liew, C.T.4
-
10
-
-
0242539445
-
The diagnostic value of hepatocyte paraffin antibody 1 in differentiating hepatocellular neoplasms from non-hepatic tumors: A Review
-
Lamps LW, Folpe AL. The diagnostic value of hepatocyte paraffin antibody 1 in differentiating hepatocellular neoplasms from non-hepatic tumors: A Review. Advanc Anat Pathol 2003; 10(1): 39-43.
-
(2003)
Advanc Anat Pathol
, vol.10
, Issue.1
, pp. 39-43
-
-
Lamps, L.W.1
Folpe, A.L.2
-
11
-
-
0037330804
-
Hep Par 1 antibody stain for the differential diagnosis of hepatocellular carcinoma: 676 tumors tested using tissue microarrays and conventional tissue sections
-
Fan Z, Rijn MVD, Montgomery K, et al. Hep Par 1 antibody stain for the differential diagnosis of hepatocellular carcinoma: 676 tumors tested using tissue microarrays and conventional tissue sections. Mod Pathol 2003; 16(2): 137-144.
-
(2003)
Mod Pathol
, vol.16
, Issue.2
, pp. 137-144
-
-
Fan, Z.1
Rijn, M.V.D.2
Montgomery, K.3
-
12
-
-
0036916550
-
Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma
-
Lau SK, Parkash S, Geller SA, Alsabeh R. Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma. Hum Pathol 2002; 33: 1175-1181.
-
(2002)
Hum Pathol
, vol.33
, pp. 1175-1181
-
-
Lau, S.K.1
Parkash, S.2
Geller, S.A.3
Alsabeh, R.4
-
13
-
-
2342485031
-
A mixed hepatocellular carcinoma and cholangiocarcinoma: Dual expression of biliary-type cytokeratin and hepatocyte specific marker
-
Tanaka S, Hirohashi K, Uenishi T, et al. A mixed hepatocellular carcinoma and cholangiocarcinoma: Dual expression of biliary-type cytokeratin and hepatocyte specific marker. Hep Gastroenterol 2001; 51: 839-841.
-
(2001)
Hep Gastroenterol
, vol.51
, pp. 839-841
-
-
Tanaka, S.1
Hirohashi, K.2
Uenishi, T.3
-
14
-
-
0034804327
-
Canalicular immunostaining of Neprilysin (CD10) as a diagnostic marker for hepatocellular carcinoma
-
Borscheri N, Roessner A, Röcken C. Canalicular immunostaining of Neprilysin (CD10) as a diagnostic marker for hepatocellular carcinoma. Am J Surg Pathol 2001; 25(10): 1297-303.
-
(2001)
Am J Surg Pathol
, vol.25
, Issue.10
, pp. 1297-1303
-
-
Borscheri, N.1
Roessner, A.2
Röcken, C.3
-
15
-
-
0347361589
-
Diagnostic value of HepPar1, pCEA, CD10, and CD34 expression in separating hepatocellular carcinoma from metastatic carcinoma in fine needle aspiration cytology
-
Saad RS, Luckasevic TM, Noga CM, et al. Diagnostic value of HepPar1, pCEA, CD10, and CD34 expression in separating hepatocellular carcinoma from metastatic carcinoma in fine needle aspiration cytology. Diagn Cytopathol 2004; 30: 1-6.
-
(2004)
Diagn Cytopathol
, vol.30
, pp. 1-6
-
-
Saad, R.S.1
Luckasevic, T.M.2
Noga, C.M.3
-
16
-
-
0027153274
-
Comparative Immunohistochemical study of primary and metastatic carcinoma of the liver
-
Ma CK, Zarbo RJ, Frierson HF Jr, Lee MW. Comparative Immunohistochemical study of primary and metastatic carcinoma of the liver. Am J Clin Pathol 1993; 99(5): 530-532.
-
(1993)
Am J Clin Pathol
, vol.99
, Issue.5
, pp. 530-532
-
-
Ma, C.K.1
Zarbo, R.J.2
Frierson Jr., H.F.3
Lee, M.W.4
-
17
-
-
0032952314
-
NCL-CD10-270: A new monoclonal antibody recognizing CD10 in Paraffin-embedded tissue
-
Mcintosh GG, Lodge AJ, Watson P, et al. NCL-CD10-270: A new monoclonal antibody recognizing CD10 in Paraffin-embedded tissue. Am J Pathol 1999; 154: 77-82.
-
(1999)
Am J Pathol
, vol.154
, pp. 77-82
-
-
McIntosh, G.G.1
Lodge, A.J.2
Watson, P.3
-
18
-
-
0029738819
-
The expression of cytokeratin 7, 19, and 20 in primary and metastatic carcinoma of the liver
-
Maeda T, Kajiyama K, Adachi E, et al. The expression of cytokeratin 7, 19, and 20 in primary and metastatic carcinoma of the liver. Mod Pathol 1996; 9(9): 901-909.
-
(1996)
Mod Pathol
, vol.9
, Issue.9
, pp. 901-909
-
-
Maeda, T.1
Kajiyama, K.2
Adachi, E.3
|